We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Thyrocalcitonin: Its Role in Calcium Homeostasis

Menelaos A. Aliapoulios, MD; Daniel S. Bernstein, MD; Marios C. Balodimos, MD
Arch Intern Med. 1969;123(1):88-94. doi:10.1001/archinte.1969.00300110090018.
Text Size: A A A
Published online

The discovery of a new hormone is indeed a rare and exciting occurrence. Most of the recent advances in the field of endocrinology have emanated from the chemical characterization and purification of known hormones.

The precise regulation of blood calcium under the principal control of parathyroid hormone acting on bone, intestine, and kidneys has been recognized and elucidated in the past 40 years. In 1961, this classic concept was challenged as a result of the demonstration of a second substance involved in calcium homeostasis. The historical development, present status, and possible clinical implications of this new hypocalcemic principle are the subject of this review.

The original evidence for a plasma calcium lowering hormone came from experiments on dogs by Copp and his colleagues.1-4 The thyroparathyroid apparatus was perfused with high, then low, calcium containing blood and the effluent blood returned to the systemic circulation. Hypercalcemic perfusion was found to


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment


Some tools below are only available to our subscribers or users with an online account.

8 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.